Market Access Consulting

Market Access requires a new approach to Value-based Health Care. Old tools are out, value-based methods are in. Syenza's Market Access services include market access strategy, market access skills development, and value communications strategies.

What are the benefits of our service?

Our Clients receive Market Access Landscape Reports, Payor Engagement RoadMaps, Value Dossiers, Fit-for-Purpose Workshops, and Value-Positioning Workshops.

Our Clients integrate project deliverables to refine market access strategies, and develop focused activities around the value communications strategy.

Our Clients identify and fill gaps in individual or organisational market access skills profiles to enhance launch and post-launch activities.

Quick preview of the service elements

Market Access Strategy

Support Clients mitigate market access risk by evaluating the market access landscape, comparing new technologies to current Payor reimbursement policies, developing an optimized market access strategy, and generating evidence to support access to innovations.

Market Access Skills Development

Provide market access consulting tools and workshops to strengthen regional and country-level market access and commercial teams achieve their objectives.

Value Communications Strategy

Optimize access to innovations by building evidence-driven value stories, targeted messaging, and adjusting evidence development plans to address value gaps in the market.

Ready to get started?

Contact Us

Related Articles

The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa is changing rapidly. The region is diverse, comprises many dissimilar countries, and different cultures including languages used in commerce. There are also different approaches to regulating healthcare markets, and concerns about the long-term sustainability of oil revenues shape healthcare markets. There are other […]

Read all
Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also determined […]

Read all
Pharma Market Access under a South African National Health Insurance system

Pharmaceutical market access will look very different under a South African national health insurance system. A national health insurance system would result in an integrated healthcare system founded on the principles of solidarity and redistribution of healthcare resources. Every South African would contribute to funding the national health insurance system and in return receive “free” […]

Read all
Read all articles